$ASMB
Assembly Biosciences Inc

2013 Q3 Form 10-Q Financial Statement

#000114420413060199 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q1 2012 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.180M $1.160M $1.180M
YoY Change 0.0% -34.46% -37.23%
% of Gross Profit
Research & Development $3.753M $2.609M $4.188M
YoY Change -10.38% -59.38% 14.12%
% of Gross Profit
Depreciation & Amortization $0.00 $1.267K $0.00
YoY Change 27.08%
% of Gross Profit
Operating Expenses $3.753M $2.609M $4.188M
YoY Change -10.38% -59.38% -24.54%
Operating Profit -$4.933M -$3.769M -$5.370M
YoY Change -8.14% -53.98%
Interest Expense $50.00K $50.00K $10.00K
YoY Change 400.0% 150.0% -103.85%
% of Operating Profit
Other Income/Expense, Net $51.27K $0.00
YoY Change
Pretax Income -$4.880M -$3.720M -$5.360M
YoY Change -8.96% -54.47% -7.59%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.882M -$3.723M -$5.355M
YoY Change -8.84% -54.45% -7.69%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.226M -$1.091M -$2.069M
COMMON SHARES
Basic Shares Outstanding 19.60M shares 12.93M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q1 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.20M $36.90M $23.60M
YoY Change 36.44% 18.65% -55.72%
Cash & Equivalents $32.22M $36.87M $23.56M
Short-Term Investments
Other Short-Term Assets $134.8K $200.0K $100.0K
YoY Change 34.78% -36.78% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $32.36M $37.10M $23.70M
YoY Change 36.53% 18.22% -55.62%
LONG-TERM ASSETS
Property, Plant & Equipment $7.632K $0.00 $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.632K $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $32.36M $37.10M $23.70M
Total Long-Term Assets $7.632K $0.00 $0.00
Total Assets $32.37M $37.10M $23.70M
YoY Change 36.56% 18.19% -55.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.280M $1.500M $1.800M
YoY Change 26.68% -52.27% 50.0%
Accrued Expenses $37.42K $400.0K $800.0K
YoY Change -95.32% -43.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.300M $2.000M $2.700M
YoY Change -14.81% -48.09% 125.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.300M $2.000M $2.700M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.318M $2.000M $2.700M
YoY Change -14.16% -48.72% 125.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $20.66K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $30.05M $35.10M $21.00M
YoY Change
Total Liabilities & Shareholders Equity $32.37M $37.10M $23.70M
YoY Change 36.56% 18.19% -55.62%

Cashflow Statement

Concept 2013 Q3 2013 Q1 2012 Q3
OPERATING ACTIVITIES
Net Income -$4.882M -$3.723M -$5.355M
YoY Change -8.84% -54.45% -7.69%
Depreciation, Depletion And Amortization $0.00 $1.267K $0.00
YoY Change 27.08%
Cash From Operating Activities -$4.650M -$4.370M -$5.280M
YoY Change -11.93% -28.24% 29.73%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.80M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.390M $20.75M 0.000
YoY Change 11383.79% -100.0%
NET CHANGE
Cash From Operating Activities -4.650M -$4.370M -5.280M
Cash From Investing Activities 0.000 $0.00 0.000
Cash From Financing Activities 3.390M $20.75M 0.000
Net Change In Cash -1.260M $16.38M -5.280M
YoY Change -76.14% -377.29% -112.6%
FREE CASH FLOW
Cash From Operating Activities -$4.650M -$4.370M -$5.280M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$4.650M -$4.370M -$5.280M
YoY Change -11.93% -28.24% 29.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1087876 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20489219 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32222910 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
39345 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20555644 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
30047662 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
17810186 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32365322 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4933008 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
59584 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
32357690 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
20548803 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7632 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6841 USD
CY2013Q3 us-gaap Assets
Assets
32365322 USD
CY2012Q4 us-gaap Assets
Assets
20555644 USD
CY2013Q3 us-gaap Liabilities
Liabilities
2317660 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2745458 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
220 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
20663 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
12934 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5370303 USD
us-gaap Net Income Loss
NetIncomeLoss
-105676239 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.66
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12933340 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18901717 shares
us-gaap Share Based Compensation
ShareBasedCompensation
10194293 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4188127 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12657538 shares
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110116766 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
134780 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
898213 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2280245 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1847245 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37415 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13850826 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4881742 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135334268 USD
CY2013Q3 vtus Common Stock Value Issuable
CommonStockValueIssuable
368750 USD
CY2012Q4 vtus Common Stock Value Issuable
CommonStockValueIssuable
0 USD
CY2013Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
105676239 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
92319514 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
220000 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
220000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20663301 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20663301 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12934350 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12934350 shares
CY2013Q3 vtus Common Stock Issuable Shares
CommonStockIssuableShares
125000 shares
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3753319 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1179689 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1182176 USD
CY2013Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
CY2012Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
6001496 USD
CY2013Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2012Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2865758 USD
CY2013Q3 us-gaap Interest Expense Other
InterestExpenseOther
0 USD
CY2012Q3 us-gaap Interest Expense Other
InterestExpenseOther
0 USD
us-gaap Interest Expense Other
InterestExpenseOther
4983572 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5355397 USD
us-gaap Net Income Loss
NetIncomeLoss
-13356725 USD
us-gaap Net Income Loss
NetIncomeLoss
-20999321 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19894525 shares
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
20754418 USD
vtus Proceeds From Sale Of Common Stock At Net Of Offering Costs
ProceedsFromSaleOfCommonStockAtNetOfOfferingCosts
3388095 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
935736 USD
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
29317 USD
vtus Stock Issuable During Period Value Share Based Compensation
StockIssuableDuringPeriodValueShareBasedCompensation
368750 USD
vtus Stock Issuable During Period Shares Share Based Compensation
StockIssuableDuringPeriodSharesShareBasedCompensation
125000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
1422371 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2241659 USD
vtus Stock Based Compensation Expense For Services
StockBasedCompensationExpenseForServices
29317 USD
us-gaap Depreciation
Depreciation
3351 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
315129 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18308931 USD
vtus Stock Based Compensation Expense For Services
StockBasedCompensationExpenseForServices
326313 USD
vtus Stock Based Compensation Expense For Services
StockBasedCompensationExpenseForServices
4359576449 USD
us-gaap Depreciation
Depreciation
4375 USD
us-gaap Depreciation
Depreciation
39998 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3466010 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2719380 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-74221746 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2130123 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12403656 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
227910 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
75196 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
49055 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
134780 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-427798 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
168122 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5166 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3240 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47630 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5166 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3240 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47630 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
24142513 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
4166494 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
93482174 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
11522380 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5041953 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1431603 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1573000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
730322 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2169762 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24142513 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4896816 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
106492286 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11733691 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13415355 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
32222910 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36975434 USD
CY2005Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23560079 USD
vtus Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
0 USD
vtus Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
0 USD
vtus Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
341334 USD
vtus Warrant Issued In Connection With Convertible Notes
WarrantIssuedInConnectionWithConvertibleNotes
0 USD
vtus Warrant Issued In Connection With Convertible Notes
WarrantIssuedInConnectionWithConvertibleNotes
0 USD
vtus Warrant Issued In Connection With Convertible Notes
WarrantIssuedInConnectionWithConvertibleNotes
1166989 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
14003158 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
685397 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> <b><font style="FONT-SIZE: 10pt">Use of estimates:</font></b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"> <font style="FONT-SIZE: 10pt">Significant estimates inherent in the preparation of the accompanying financial statements include the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"> <font style="FONT-SIZE: 10pt">Additionally, the Company provides a valuation allowance for deferred income tax assets when it is considered more likely than not that all or a portion of such deferred income tax assets will not be realized.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
&#160;Series A preferred stock is convertible into 10 common shares of the Company&#8217;s common stock at any time at the holder&#8217;s option
CY2013Q3 vtus Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
861046 shares
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2005-10-07
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20800000 USD
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5594521 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3133606 shares
CY2011Q3 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
300000 USD
CY2011Q3 us-gaap Deferred Compensation Arrangement With Individual Distributions Paid
DeferredCompensationArrangementWithIndividualDistributionsPaid
200000 USD
CY2011Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
9.85
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
874651 shares
vtus Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
vtus Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
0 shares
vtus Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
13605 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
861046 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4200000 USD
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6670000 shares
CY2013Q1 vtus Stock Issued During Period Price Per Share New Issues
StockIssuedDuringPeriodPricePerShareNewIssues
2.50
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
18028686 USD
vtus Restricted Stock Expensed Percentage
RestrictedStockExpensedPercentage
0.25 pure
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1135000 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
30000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2013Q3 vtus Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
7.77
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
vtus Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0
vtus Class Of Warrant Or Right Expired In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExpiredInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0
CY2012Q4 vtus Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
7.67
vtus Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
7.77
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1878475 shares
vtus Share Based Compensation Arrangement By Share Based Payment Award Option Vested And Expected To Vest Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionVestedAndExpectedToVestGranted
280000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2158475 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1597449 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.72
vtus Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestGrantedWeightedAverageExercisePrice
2.94
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.23
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
CY2013Q3 vtus Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
278672 USD
CY2013Q3 vtus Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
625436 USD
CY2013Q3 vtus Future Stock Based Compensation Expense Year Four
FutureStockBasedCompensationExpenseYearFour
146908 USD
CY2013Q3 vtus Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
99920 USD
CY2013Q3 vtus Future Stockbased Compensation Expense Year Six
FutureStockbasedCompensationExpenseYearSix
20239 USD
CY2013Q3 vtus Future Stock Based Compensation Expense Year Five
FutureStockBasedCompensationExpenseYearFive
1171175 USD
vtus Class Of Warrant Or Right Expirations In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
1.24
vtus Share Based Compensation Arrangement By Share Based Payment Award Restricted Value Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedValueGrantedInPeriod
117885 USD
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
51266 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
14906 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
154009 USD

Files In Submission

Name View Source Status
0001144204-13-060199-index-headers.html Edgar Link pending
0001144204-13-060199-index.html Edgar Link pending
0001144204-13-060199.txt Edgar Link pending
0001144204-13-060199-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v358927_10q.htm Edgar Link pending
v358927_ex31-1.htm Edgar Link pending
v358927_ex31-2.htm Edgar Link pending
v358927_ex32-1.htm Edgar Link pending
v358927_ex32-2.htm Edgar Link pending
vtus-20130930.xml Edgar Link completed
vtus-20130930.xsd Edgar Link pending
vtus-20130930_cal.xml Edgar Link unprocessable
vtus-20130930_def.xml Edgar Link unprocessable
vtus-20130930_lab.xml Edgar Link unprocessable
vtus-20130930_pre.xml Edgar Link unprocessable